Table 1.
S. no. | Sex | Age (years) | Duration of disease (months) | Onset of GAE | Type of GAE | Follow-up (months) |
---|---|---|---|---|---|---|
1 | F | 25 | 8 | Synchronous | Bilateral | 38 |
2 | F | 19 | 14 | Synchronous | Unilateral | 36 |
3 | F | 31 | 10 | Synchronous | Bilateral | 36 |
4 | M | 42 | 24 | Prechronous | Bilateral | 32 |
5 | F | 50 | 12 | Synchronous | Bilateral | 32 |
6 | F | 38 | 3 | Metachronous | Bilateral | 30 |
7 | F | 18 | 12 | Synchronous | Bilateral | 27 |
8 | F | 55 | 36 | Synchronous | Bilateral | 26 |
9 | F | 44 | 40 | Synchronous | Unilateral | 24 |
10 | M | 48 | 24 | Prechronous | Bilateral | 24 |
11 | F | 23 | 8 | Synchronous | Bilateral | 21 |
12 | M | 21 | 12 | Synchronous | Bilateral | 18 |
13 | F | 34 | 18 | Synchronous | Unilateral | 16 |
14 | F | 41 | 20 | Prechronous | Bilateral | 15 |
15 | F | 29 | 4 | Synchronous | Bilateral | 14 |